IOBT
Price
$1.83
Change
-$0.06 (-3.17%)
Updated
Aug 8 closing price
Capitalization
119.24M
One day until earnings call
RAPT
Price
$9.93
Change
-$0.32 (-3.12%)
Updated
Aug 8 closing price
Capitalization
162.24M
Interact to see
Advertisement

IOBT vs RAPT

Header iconIOBT vs RAPT Comparison
Open Charts IOBT vs RAPTBanner chart's image
IO Biotech
Price$1.83
Change-$0.06 (-3.17%)
Volume$358.35K
Capitalization119.24M
RAPT Therapeutics
Price$9.93
Change-$0.32 (-3.12%)
Volume$25.13K
Capitalization162.24M
IOBT vs RAPT Comparison Chart in %
Loading...
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IOBT vs. RAPT commentary
Aug 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOBT is a Hold and RAPT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 11, 2025
Stock price -- (IOBT: $1.83 vs. RAPT: $9.93)
Brand notoriety: IOBT and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOBT: 100% vs. RAPT: 26%
Market capitalization -- IOBT: $119.24M vs. RAPT: $162.24M
IOBT [@Biotechnology] is valued at $119.24M. RAPT’s [@Biotechnology] market capitalization is $162.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOBT’s FA Score shows that 0 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • IOBT’s FA Score: 0 green, 5 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, IOBT is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOBT’s TA Score shows that 3 TA indicator(s) are bullish while RAPT’s TA Score has 3 bullish TA indicator(s).

  • IOBT’s TA Score: 3 bullish, 5 bearish.
  • RAPT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both IOBT and RAPT are a bad buy in the short-term.

Price Growth

IOBT (@Biotechnology) experienced а -17.57% price change this week, while RAPT (@Biotechnology) price change was -5.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.11%. For the same industry, the average monthly price growth was +5.28%, and the average quarterly price growth was +13.38%.

Reported Earning Dates

IOBT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+0.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPT($162M) has a higher market cap than IOBT($119M). IOBT YTD gains are higher at: 98.913 vs. RAPT (-21.440). IOBT has less debt than RAPT: IOBT (1.76M) vs RAPT (3.84M).
IOBTRAPTIOBT / RAPT
Capitalization119M162M73%
EBITDA-96.7MN/A-
Gain YTD98.913-21.440-461%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash37.1MN/A-
Total Debt1.76M3.84M46%
TECHNICAL ANALYSIS
Technical Analysis
IOBTRAPT
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 14 days ago
90%
Bullish Trend 19 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IOBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ITPC90.004.90
+5.76%
Intrepid Capital Corp.
MCVEF19.83N/A
N/A
Medicover AB
MVLY15.55N/A
N/A
Mission Valley Bancorp
WHTAF40.01N/A
N/A
WashTec AG AUGSBURG
DUAVF310.00-2.50
-0.80%
DASSAULT AVIATION

IOBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOBT has been loosely correlated with DYN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if IOBT jumps, then DYN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOBT
1D Price
Change %
IOBT100%
-3.17%
DYN - IOBT
34%
Loosely correlated
N/A
GLMD - IOBT
33%
Loosely correlated
+5.84%
RGNX - IOBT
30%
Poorly correlated
-0.63%
RAPT - IOBT
29%
Poorly correlated
-3.12%
TPST - IOBT
29%
Poorly correlated
+4.69%
More

RAPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPT has been loosely correlated with TRAW. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPT jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPT
1D Price
Change %
RAPT100%
-3.12%
TRAW - RAPT
45%
Loosely correlated
+1.35%
SLGL - RAPT
40%
Loosely correlated
+9.45%
AVXL - RAPT
38%
Loosely correlated
-1.20%
CTMX - RAPT
35%
Loosely correlated
+11.90%
PDSB - RAPT
33%
Poorly correlated
-0.89%
More